Matthew Holt: Don’t expect any big health policy changes in a Kamala Harris administration.
How much progress have scientists made on anti-aging research?
Category: Health Economics & Costs
Saturday Links
- Henderson: the case for immigration.
- Why inequality can be a good thing.
- Chronically ill patients with high deductible health plans are highly sensitive to out-of-pocket costs for telemedicine.
- Harris would add $1.7 trillion to federal spending. And that doesn’t include Medicare for All.
- When drug companies assist patients in paying for their drugs, should that assistance count toward the patient’s insurance plan deductibles and coinsurance?
- Unintended consequences: Could the IRA bill lead to increased enrollment in Medicare Advantage plans?
WSJ: People Are Getting Hip and Knee Replacements at a Much Younger Age
There are 77 million Baby Boomers and people age 60 and older. Among other things, many will begin to feel the pain of joints that are wearing out and will need hip or knee replacement.
Friday Links
- Kamala’s Medicare for All plan would be costly. Very costly.
- Around 60% of baby and toddler food items sold in major U.S. retailers fail to meet international nutritional guidelines.
- 1.81 billion people are “energy poor.”
- University of Chicago economist Casey Mulligan: Kamala Harris’s votes for ARP and IRA were responsible for at least half of the excess inflation experienced during the Biden presidency.
- Medicare’s actuaries estimate because of the IRA, the average cost of providing drug coverage will rise by 179% next year. In an attempt to avert that, the Biden/Harris administration is planning to give Medicare Part D plans $70 billion, three-year “premium stabilization” program — “a massive bailout to insurers to paper over the increased costs of the Inflation Reduction Act.”